Diabetic nephropathy in children and adolescents

被引:42
作者
Bogdanovic, Radovan [1 ]
机构
[1] Inst Mother & Child Healthcare Serbia Dr Vukan Cu, 8 Radoja Dakica St, Belgrade 11070, Serbia
关键词
diabetic nephropathy; children; adolescents; risk factors; microalbuminuria; screening; prevention; treatment;
D O I
10.1007/s00467-007-0583-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Type 1 diabetes mellitus (T1DM) commonly occurs in childhood or adolescence, although the rising prevalence of type 2 diabetes mellitus (T2DM) in these age groups is now being seen worldwide. Diabetic nephropathy (DN) develops in 15-20% of subjects with T1DM and in similar or higher percentage of T2DM patients, causing increased morbidity and premature mortality. Although overt DN or kidney failure caused by either type of diabetes are very uncommon during childhood or adolescence, diabetic kidney disease in susceptible patients almost certainly begins soon after disease onset and may accelerate during adolescence, leading to microalbuminuria or incipient DN. Therefore, all diabetics warrant ongoing assessment of kidney function and screening for the earliest manifestations of renal injury. Pediatric health care professionals ought to understand about risk factors, strategy for prevention, method for screening, and treatment of early DN. This review considers each form of diabetes separately, including natural history, risk factors for development, screening for early manifestations, and strategy recommended for prevention and treatment of DN in children and adolescents.
引用
收藏
页码:507 / 525
页数:19
相关论文
共 248 条
[31]   Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects [J].
Bruno, G ;
CavalloPerin, P ;
Bargero, G ;
Borra, M ;
Calvi, V ;
DErrico, N ;
Deambrogio, P ;
Pagano, G .
DIABETES CARE, 1996, 19 (01) :43-47
[32]   MICROALBUMINURIA AND NEPHROPATHY IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
CAMPBELL, FM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 73 (01) :4-7
[33]   Enhancing the predictive value of urinary albumin for diabetic nephropathy [J].
Caramori, M. Luiza ;
Fioretto, Paola ;
Mauer, Michael .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02) :339-352
[34]   Diabetes and nephropathy [J].
Caramori, ML ;
Mauer, M .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (03) :273-282
[35]   Low glomerular filtration rate in normoalbuminuric type 1 dihibetic patients - An indicator of more advanced glomerular lesions [J].
Caramori, ML ;
Fioretto, P ;
Mauer, M .
DIABETES, 2003, 52 (04) :1036-1040
[36]   The need for early predictors of diabetic nephropathy risk - Is albumin excretion rate sufficient? [J].
Caramori, ML ;
Fioretto, P ;
Mauer, M .
DIABETES, 2000, 49 (09) :1399-1408
[37]   Chip electrophoresis as a method for quantifying total microalbuminuria [J].
Chan, Owen T. M. ;
Herold, David A. .
CLINICAL CHEMISTRY, 2006, 52 (11) :2141-2146
[38]  
CHASE HP, 1991, CLIN CHEM, V37, P2048
[39]   Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J].
Chaturvedi, N .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) :370-379
[40]   THE RELATIONSHIP BETWEEN SMOKING AND MICROVASCULAR COMPLICATIONS IN THE EURODIAB IDDM COMPLICATIONS STUDY [J].
CHATURVEDI, N ;
STEPHENSON, JM ;
FULLER, JH ;
KARAMANOS, B ;
TOUNTAS, C ;
KOFINIS, A ;
PETROU, K ;
KATSILAMBROS, N ;
GIORGINO, R ;
CIGNARELLI, M ;
DECICCO, ML ;
RAMUNNI, I ;
IONESCUTIRGOVISTE, C ;
IOSIF, CM ;
PITEI, D ;
BULIGESCU, S ;
TAMAS, G ;
KERENYI, Z ;
AHMED, AM ;
TOTH, J ;
KEMPLER, P ;
MUNTONI, S ;
SONGINI, M ;
STABILINI, M ;
FOSSARELLO, M ;
PINTUS, S ;
MUNTONI, S ;
FERRISS, JB ;
CRONIN, CC ;
WHYTE, AE ;
CLEARY, PE ;
TOELLER, M ;
KLISCHAN, A ;
FORST, T ;
GRIES, FA ;
WAGENER, W ;
ROTTIERS, RR ;
PRIEM, H ;
EBELING, P ;
SINISALO, M ;
KOIVISTO, VA ;
IDZIORWALUS, B ;
SOLNICA, B ;
SZOPINSKACIBA, L ;
SOLNICA, K ;
KRANS, HMJ ;
LEMKES, HHPJ ;
JANSEN, JJ ;
BRACHTER, J ;
NUNESCORREA, J .
DIABETES CARE, 1995, 18 (06) :785-792